From: The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population
Age | Na | Female | Male | PMR | Female | Male | GCA | Female | Male | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N | Pr (95 % CI) | N | Pr (95 % CI) | N | Pr (95 % CI) | N | Pr (95 % CI) | N | Pr (95 % CI) | N | Pr (95 % CI) | ||||
55–60 | 978 | 500 | 478 | 1 | 0.10 (0.00, 0.30) | 1 | 0.20 (0.00, 0.59) | 0 | 1 | 0.10 (0.00, 0.30) | 0 | 1 | 0.21 (0.00, 0.62) | ||
60–69 | 1902 | 989 | 913 | 20 | 1.05 (0.59, 1.51) | 15 | 1.52 (0.76, 2.28) | 5 | 0.55 (0.07, 1.03) | 3 | 0.16 (0.00, 0.34) | 3 | 0.30 (0.00, 0.65) | 0 | |
70–79 | 1412 | 700 | 712 | 49 | 3.47 (2.52, 4.43) | 33 | 4.71 (3.14, 6.28) | 16 | 2.25 (1.16, 3.33) | 6 | 0.43 (0.09, 0.76) | 4 | 0.57 (0.01, 1.13) | 2 | 0.28 (0.00, 0.67) |
80–89 | 695 | 395 | 300 | 40 | 5.76 (4.02, 7.49) | 20 | 5.06 (2.90, 7.22) | 20 | 6.67 (3.84, 9.49) | 9 | 1.30 (0.45, 2.14) | 5 | 1.27 (0.16, 2.37) | 4 | 1.33 (0.04, 2.63) |
90–100 | 166 | 116 | 50 | 7 | 4.22 (1.16, 7.27) | 5 | 4.31 (0.62, 8.01) | 2 | 4.00 (0.00, 9.43) | 2 | 1.72 (0.00, 4.09) | 2 | 1.72 (0.00, 4.09) | 0 | |
100+ | 6 | 6 | 0 | 0 | N/A | N/A | 0 | N/A | N/A | ||||||
Total | 5159 | 2706 | 2453 | 117 | 2.27 (1.86, 2.67) | 74 | 2.74 (21.12, 3.35) | 43 | 1.75 (1.23, 2.27) | 21 | 0.41 % (0.23, 0.58) | 14 | 0.52 (0.25, 0.79) | 7 | 0.29 (0.07, 0.50) |